James B. McNally, SVP, Marketing and Business Development at GenMark Diagnostics, Inc. (GNMK), sold 2,288 shares at $5.43 ($12K) on 2019-11-25, disclosed to the SEC on 2019-11-26.
Seasonal sale ($12k) by SVP, Marketing and Business Development — this insider has traded GNMK in November in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| GNMK | SELL | 2019-08-30 | $14K | — | Filing → |
| GNMK | SELL | 2019-08-08 | $6K | — | Filing → |
| GNMK | SELL | 2019-05-31 | $14K | — | Filing → |